High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose?
- PMID: 34943531
- PMCID: PMC8700001
- DOI: 10.3390/diagnostics11122293
High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose?
Abstract
Imaging plays a pivotal role in systemic sclerosis for both diagnosis management of pulmonary complications, and high-resolution computed tomography (HRCT) is the most sensitive technique for the evaluation of systemic sclerosis-associated interstitial lung disease (SSc-ILD). Indeed, several studies have demonstrated that HRCT helps radiologists and clinicians to make a correct diagnosis on the basis of recognised typical patterns for SSc-ILD. Most SSc patients affected by ILD have a non-specific interstitial pneumonia pattern (NISP) on HRCT scan, whilst a minority of cases fulfil the criteria for usual interstitial pneumonia (UIP). Moreover, several recent studies have demonstrated that lung ultrasound (LUS) is an emergent tool in SSc diagnosis and follow-up, although its role is still to be confirmed. Therefore, this article aims at evaluating the role of LUS in SSc screening, aimed at limiting the use of CT to selected cases.
Keywords: diagnostic imaging; high-resolution computed tomography (HRCT); interstitial lung disease (ILD); lung ultrasound (LUS); systemic sclerosis (SSc); systemic sclerosis-associated interstitial lung disease (SSc-ILD).
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Distler O., Assassi S., Cottin V., Cutolo M., Danoff S.K., Denton C.P., Distler J.H., Hoffmann-Vold A.-M., Johnson S.R., Ladner U.M., et al. Predictors of progression in systemic sclerosis patients with interstitial lung disease. Eur. Respir. J. 2020;55:1902026. doi: 10.1183/13993003.02026-2019. - DOI - PMC - PubMed
-
- Tyndall A.J., Bannert B., Vonk M., Airò P., Cozzi F., Carreira P.E., Bancel D.F., Allanore Y., Müller-Ladner U., Distler O., et al. Causes and risk factors for death in systemic sclerosis: A study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann. Rheum. Dis. 2010;69:1809–1815. doi: 10.1136/ard.2009.114264. - DOI - PubMed
-
- Volkmann E.R., Tashkin D.P., Sim M., Li N., Goldmuntz E., Keyes-Elstein L., Pinckney A., Furst D.E., Clements P.J., Khanna D., et al. Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts. Ann. Rheum. Dis. 2018;78:122–130. doi: 10.1136/annrheumdis-2018-213708. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
